Carmat SA (ALCAR.PA)
EUR 1.0
(-1.09%)
EUR 1.0
(-1.09%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -53.86 Million EUR | -0.41% |
| 2022 | -53.68 Million EUR | 13.24% |
| 2021 | -61.87 Million EUR | -67.39% |
| 2020 | -36.96 Million EUR | 13.33% |
| 2019 | -42.64 Million EUR | -2.2% |
| 2018 | -41.72 Million EUR | -42.77% |
| 2017 | -29.22 Million EUR | -27.19% |
| 2016 | -22.98 Million EUR | -30.97% |
| 2015 | -17.54 Million EUR | 3.93% |
| 2014 | -18.26 Million EUR | -24.71% |
| 2013 | -14.64 Million EUR | 14.8% |
| 2012 | -17.18 Million EUR | -27.89% |
| 2011 | -13.44 Million EUR | -73.74% |
| 2010 | -7.73 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -26.2 Million EUR | 0.0% |
| 2023 Q2 | -26.67 Million EUR | 0.0% |
| 2023 Q4 | -27.22 Million EUR | 0.0% |
| 2023 FY | -53.9 Million EUR | -0.41% |
| 2022 FY | -53.68 Million EUR | 13.24% |
| 2022 Q2 | -25.99 Million EUR | 0.0% |
| 2022 Q4 | -27.69 Million EUR | 0.0% |
| 2021 Q4 | -35.51 Million EUR | 0.0% |
| 2021 FY | -61.87 Million EUR | -67.39% |
| 2021 Q2 | -26.35 Million EUR | 0.0% |
| 2020 Q4 | -16.12 Million EUR | 0.0% |
| 2020 Q2 | -20.83 Million EUR | 0.0% |
| 2020 FY | -36.96 Million EUR | 13.33% |
| 2019 Q2 | -23.97 Million EUR | 0.0% |
| 2019 Q4 | -18.67 Million EUR | 0.0% |
| 2019 FY | -42.64 Million EUR | -2.2% |
| 2018 FY | -41.72 Million EUR | -42.77% |
| 2018 Q2 | -18.86 Million EUR | 0.0% |
| 2018 Q4 | -22.86 Million EUR | 0.0% |
| 2017 Q2 | -14.09 Million EUR | 0.0% |
| 2017 FY | -29.22 Million EUR | -27.19% |
| 2017 Q4 | -15.13 Million EUR | 0.0% |
| 2016 Q2 | -10.17 Million EUR | 0.0% |
| 2016 FY | -22.98 Million EUR | -30.97% |
| 2016 Q4 | -12.8 Million EUR | 0.0% |
| 2015 FY | -17.54 Million EUR | 3.93% |
| 2015 Q4 | -9.34 Million EUR | 0.0% |
| 2015 Q2 | -8.19 Million EUR | 0.0% |
| 2014 FY | -18.26 Million EUR | -24.71% |
| 2014 Q2 | -9.92 Million EUR | 0.0% |
| 2014 Q4 | -8.33 Million EUR | 0.0% |
| 2013 Q1 | -3.66 Million EUR | 0.0% |
| 2013 Q4 | -9.7 Million EUR | -165.21% |
| 2013 FY | -14.64 Million EUR | 14.8% |
| 2013 Q3 | -3.66 Million EUR | 25.81% |
| 2013 Q2 | -4.93 Million EUR | -34.79% |
| 2012 Q4 | -3.66 Million EUR | 14.8% |
| 2012 Q1 | -4.29 Million EUR | 0.0% |
| 2012 FY | -17.18 Million EUR | -27.89% |
| 2012 Q3 | -4.29 Million EUR | 0.0% |
| 2012 Q2 | -4.29 Million EUR | 0.0% |
| 2011 Q1 | -3.36 Million EUR | 0.0% |
| 2011 Q3 | -3.36 Million EUR | 0.0% |
| 2011 Q4 | -4.29 Million EUR | -27.54% |
| 2011 FY | -13.44 Million EUR | -73.74% |
| 2011 Q2 | -3.36 Million EUR | 0.0% |
| 2010 FY | -7.73 Million EUR | 0.0% |
| 2010 Q4 | -3.36 Million EUR | -74.22% |
| 2010 Q1 | -1.93 Million EUR | 0.0% |
| 2010 Q3 | -1.93 Million EUR | 0.0% |
| 2010 Q2 | -1.93 Million EUR | 0.0% |
| 2009 Q4 | -1.93 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Affluent Medical SA | -15.65 Million EUR | -244.145% |
| Bluelinea Société Anonyme | -1.62 Million EUR | -3225.247% |
| Diagnostic Medical Systems S.A. | -4.94 Million EUR | -989.143% |
| Euromedis Groupe | 13.11 Million EUR | 510.89% |
| Eurobio Scientific Société anonyme | 4.83 Million EUR | 1214.147% |
| Ikonisys S.A. | -2.26 Million EUR | -2275.547% |
| Implanet S.A. | -6.67 Million EUR | -706.905% |
| Median Technologies SA | -22.98 Million EUR | -134.396% |
| SpineGuard SA | -4.18 Million EUR | -1187.681% |
| Theraclion SA | -3.67 Million EUR | -1365.821% |
| Euroapi S.A. | -189.7 Million EUR | 71.603% |
| Guerbet SA | 23.86 Million EUR | 325.714% |
| Ion Beam Applications SA | -9.11 Million EUR | -491.317% |
| Koninklijke Philips N.V. | -466 Million EUR | 88.44% |
| Sequana Medical NV | -32.56 Million EUR | -65.427% |